Description

3,4-Dihydro-4-Oxo-5,6-Cyclohexano-3-((5-(Trifluoromethyl)Benzothiazol-2-Yl)Methyl)-1-Pyridazineacetic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel active pharmaceutical ingredients (APIs) targeting specific therapeutic pathways. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the development of new drug candidates.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly those targeting neurological or inflammatory pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes in drug discovery.
• Active Pharmaceutical Ingredient (API) Synthesis: Serves as a precursor in multi-step synthetic routes for complex target molecules.
• Biochemical Research: Potential tool compound for studying enzyme inhibition or receptor binding due to its benzothiazole and pyridazine motifs.
• Fine Chemical Production: Employed in the custom synthesis of specialized, high-value organic compounds for various industrial applications.

Basic Information

Product Name	3,4-Dihydro-4-Oxo-5,6-Cyclohexano-3-((5-(Trifluoromethyl)Benzothiazol-2-Yl)Methyl)-1-Pyridazineacetic Acid
CAS No.	140926-49-4
Molecular Formula	C22H20F3N3O3S
Molecular Weight	463.47 g/mol
Synonyms	1-Pyridazineacetic acid, 3,4-dihydro-4-oxo-5,6-cyclohexano-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-; 3-((5-(Trifluoromethyl)benzothiazol-2-yl)methyl)-4-oxo-5,6-cyclohexano-3,4-dihydro-1-pyridazineacetic acid; 140926-49-4; UNII-8V7I4H6W6H; 8V7I4H6W6H; SCHEMBL218062; DTXSID60622376; BCP31063
EINECS	Contact for details

Quality Control

Our 3,4-Dihydro-4-Oxo-5,6-Cyclohexano-3-((5-(Trifluoromethyl)Benzothiazol-2-Yl)Methyl)-1-Pyridazineacetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with full traceability are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.